Transcatheter Closure of Perimembranous Ventricular Septal Defect Using KONAR-MF™: A Multicenter Experience
Pediatric Cardiology · 2025
DOI: 10.1007/s00246-024-03505-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Cardiology, 2025. Verfasst von Nageswara Rao Koneti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Plot no: 22, Road no: 10, Banjara Hills, Hyderabad, 5000034, India. drkoneti@…. Hauptthemen laut MEDLINE: Heart Septal Defects, Ventricular, Septal Occluder Device, Cardiac Catheterization. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Transcatheter closure of perimembranous ventricular septal defect (PmVSD) is an established procedure. However, the occurrence of complete heart block limits its scope. The newer KONAR-MF™ occluder has specific design characteristics that may improve the safety of PmVSD closure. The objective of the study was to describe the efficacy and mid-term follow-up of transcatheter closure of PmVSD using KONAR-MF™. The study was conducted prospectively in 3 Indian centers (January 2018-December 2022). PmVSD closure was done by both antegrade and retrograde methods, and patients were followed up at 1, 3, 6, 12 months, and annually after that. 121 out of 123 patients were included with the following characteristics: median age 4.4 (0.18-40) years; weight 15 (2.1-88) kg; mean Qp/Qs ratio 1.87 ± 0.52 and pulmonary artery mean pressure: 22 ± 6.9 mmHg. The procedure was successful in all but 3; the device was removed due to significant residual shunt (n = 2) and new development of aortic regurgitation (AR) (≥ mild) in 1. The median defect size was 5.2 (2.5-12) mm. Device sizes from 6/4 to 14/12 were deployed (median fluoroscopy time 13.3 min; range 3.6-47.8). Shunt occlusion rates were 90%-Immediate, 95%-pre-discharge, and 97%-1 month, with no instances of complete heart block after the procedure and during follow-up. Six had new onset AR (mild: 2, trivial 4), and one had increased tricuspid regurgitation. All patients were well during follow-up (median: 20 months; range: 6-46). The new KONAR-MF™ occluder appears to be a promising and safe alternative for the closure of the PmVSD; further long-term follow is merited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Plot no: 22, Road no: 10, Banjara Hills, Hyderabad, 5000034, India. drkoneti@yahoo.com.
- Consultant Pediatric Cardiology, Amrita Hospital Sector 88, Faridabad, India.
- Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Plot no: 22, Road no: 10, Banjara Hills, Hyderabad, 5000034, India.
- Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Kochi, India.
Zitieren
APA
Koneti, N. R., Azad, S., Bakhru, S., Dhulipudi, B., Sitaraman, R., & Kumar, R. K. (2025). Transcatheter Closure of Perimembranous Ventricular Septal Defect Using KONAR-MF™: A Multicenter Experience. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03505-w
Vancouver
Koneti NR, Azad S, Bakhru S, Dhulipudi B, Sitaraman R, Kumar RK. Transcatheter Closure of Perimembranous Ventricular Septal Defect Using KONAR-MF™: A Multicenter Experience. Pediatric Cardiology. 2025. doi:10.1007/s00246-024-03505-w
BibTeX
@article{Koneti2025,
author = {Koneti, Nageswara Rao and Azad, Sushil and Bakhru, Shweta and Dhulipudi, Bhargavi and Sitaraman, Radhakrishnan and Kumar, Raman Krishna},
title = {Transcatheter Closure of Perimembranous Ventricular Septal Defect Using KONAR-MF™: A Multicenter Experience},
journal = {Pediatric Cardiology},
year = {2025},
doi = {10.1007/s00246-024-03505-w}
}
EUVIMED